Research Compound GLOW

Research Compound GLOW is a combined research preparation for analytical and in vitro work, with a total declared content of 70 mg.

Composition

GLOW combines three research materials: GHK-Cu, BPC-157 and TB-500. The ratio of components is stated in the product specification. The total of 70 mg refers to the sum of all components, not the amount of any single molecule.

Rationale for the combination

Each component covers a different area of cell biology. GHK-Cu is studied in fibroblast and extracellular matrix models, BPC-157 in models of angiogenesis and vascular signalling, and thymosin beta-4 in models of actin dynamics and cell migration. The combination allows these processes to be studied in the same experimental system.

Main research areas

• extracellular matrix and fibroblasts
• angiogenesis and vascular models
• cell migration
• stability and interactions of components in a mixture

Analytical considerations

With a three-component mixture, the identity and amount of each molecule must be verified separately. In addition, the copper ion from GHK-Cu may affect the stability of other peptides in solution, another reason for careful interpretation of analytical data.

Level of evidence

Evidence relates to the individual components. Synergy of the finished combination has not been confirmed.

Related

KLOW additionally contains KPV: see KLOW.

Research use only: for laboratory, analytical and in vitro research only; not for use in humans or animals. Guidance on batch documentation is available in our COA guide.